Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Neuroblastoma (SH-SY5Y, apoptosis, blebbing)
[{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f6/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f6/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f5/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f5/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f4/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f4/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f3/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f3/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f2/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f2/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f1/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f1/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68f0/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68f0/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ef/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ef/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ee/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ee/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ed/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ed/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ec/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ec/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68eb/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68eb/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ea/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ea/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e9/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e9/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e8/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e8/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e7/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e7/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e6/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e6/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e5/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e5/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e4/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e4/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e3/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e3/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e2/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e2/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e1/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e1/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68e0/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68e0/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68df/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68df/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68de/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68de/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68dd/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68dd/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68dc/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68dc/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68db/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68db/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68da/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68da/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d9/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d9/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d8/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d8/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d7/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d7/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d6/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d6/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d5/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d5/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d4/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d4/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d3/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d3/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d2/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d2/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d1/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d1/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68d0/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68d0/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68cf/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68cf/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ce/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ce/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68cd/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68cd/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68cc/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68cc/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68cb/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68cb/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68ca/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68ca/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68c9/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68c9/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68c8/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68c8/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68c7/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68c7/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68c6/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68c6/630633e17c75bb00281a685f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630635527c75bb00281a68c5/630633e17c75bb00281a685f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630635527c75bb00281a68c5/630633e17c75bb00281a685f.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
neuroblastoma,apoptosis,blebbing,cell death,programmed cell death,nuclear fragmentation,necrosis,capsase,protease,degradation,atrophy,SH-sy5y,SK-N-SH,parkinson,neurogenesis,differentiated,differentiation,n type,SH-sy5y
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
